Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.845
-0.140 (-4.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Processa Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.54 | 1.19 | 4.71 | 6.5 | 16.5 | Upgrade
|
| Cash & Short-Term Investments | 5.54 | 1.19 | 4.71 | 6.5 | 16.5 | Upgrade
|
| Cash Growth | 364.77% | -74.69% | -27.64% | -60.58% | 7.01% | Upgrade
|
| Other Receivables | - | - | - | - | 0.07 | Upgrade
|
| Receivables | - | - | - | - | 0.07 | Upgrade
|
| Prepaid Expenses | 0.13 | 0.69 | 0.93 | 1.88 | 1.76 | Upgrade
|
| Total Current Assets | 5.67 | 1.88 | 5.63 | 8.39 | 18.33 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.08 | 0.15 | 0.23 | 0.07 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 8.06 | Upgrade
|
| Other Long-Term Assets | 2.14 | 1.27 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 7.81 | 3.23 | 5.79 | 8.62 | 26.46 | Upgrade
|
| Accounts Payable | 1.06 | 0.88 | 0.31 | 0.33 | 0.22 | Upgrade
|
| Accrued Expenses | 1.18 | 0.58 | 0.15 | 0.4 | 0.28 | Upgrade
|
| Current Portion of Leases | - | 0.07 | 0.08 | 0.08 | 0.07 | Upgrade
|
| Other Current Liabilities | - | - | 0.19 | 0.19 | 0.4 | Upgrade
|
| Total Current Liabilities | 2.24 | 1.53 | 0.73 | 1 | 0.97 | Upgrade
|
| Long-Term Leases | - | 0 | 0.07 | 0.15 | 0.01 | Upgrade
|
| Total Liabilities | 2.24 | 1.53 | 0.8 | 1.15 | 0.98 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 106.66 | 89.22 | 80.66 | 72.02 | 62.31 | Upgrade
|
| Retained Earnings | -100.78 | -87.22 | -75.37 | -64.25 | -36.82 | Upgrade
|
| Treasury Stock | -0.3 | -0.3 | -0.3 | -0.3 | - | Upgrade
|
| Shareholders' Equity | 5.58 | 1.7 | 4.99 | 7.47 | 25.49 | Upgrade
|
| Total Liabilities & Equity | 7.81 | 3.23 | 5.79 | 8.62 | 26.46 | Upgrade
|
| Total Debt | - | 0.07 | 0.15 | 0.23 | 0.08 | Upgrade
|
| Net Cash (Debt) | 5.54 | 1.12 | 4.56 | 6.27 | 16.42 | Upgrade
|
| Net Cash Growth | 395.34% | -75.46% | -27.39% | -61.79% | 8.82% | Upgrade
|
| Net Cash Per Share | 4.23 | 9.13 | 86.84 | 194.73 | 535.89 | Upgrade
|
| Filing Date Shares Outstanding | 2.66 | 0.21 | 0.11 | 0.05 | 0.03 | Upgrade
|
| Total Common Shares Outstanding | 2.57 | 0.15 | 0.05 | 0.03 | 0.03 | Upgrade
|
| Working Capital | 3.43 | 0.35 | 4.9 | 7.39 | 17.36 | Upgrade
|
| Book Value Per Share | 2.17 | 11.45 | 96.99 | 232.94 | 811.11 | Upgrade
|
| Tangible Book Value | 5.58 | 1.7 | 4.99 | 7.47 | 17.43 | Upgrade
|
| Tangible Book Value Per Share | 2.17 | 11.45 | 96.99 | 232.94 | 554.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.